Heterogenicity of disease pathogenesis and belated therapeutic intervention are among the main challenges that hamper realization of clinical benefits to patients with CNS diseases. For complex diseases with uncertain and multifactorial causes, targeting the fundamental pathophysiology of degeneration itself may offer a broad spectrum of therapeutic efficacies independent of specific pathogenesis.
4B Tech focuses on promoting neuroprotection/synaptic repair and suppressing neuroinflammation, the two pathophysiologic hallmarks of all neurodegenerative diseases, thereby slowing down or hauling disease progressions.
